Authors performed a retrospective study to evaluate the safety and efficacy of an alpha-blocker (Tamsulosin 0,4mg once a day) as a MET in pregnant women. Authors retrospectively identified pregnant patients who presented with renal colic at their hospital from 2000 to 2015. Patients who received Tamsulosin were compared to those who did not receive any MET. Efficacy of stone passage rate and intervention rate was assessed and compared.
Theriault Benoit, MD, reported that there was no difference in maternal age of the patients, prior incidents of urolithiasis. All perinatal outcomes also showed no difference between the groups (table 1).
Authors concluded that spontaneous passage was superior in the MET group, however, did not reach the statistical difference. Longer passage time was demonstrated in MET group. There limitations to the study including its retrospective design and lack of stone size. These factors may have significantly impacted the study outcomes. Further, prospective randomized studies are needed to elucidate the role of MET in pregnant patients with urolithiasis.
Presented by: Theriault Benoit, MD, Division of Surgery, Urology Program, University Hospital of Quebec - Laval University
C-Authors: Morin Fannie, Julien Anne-Sophie, Perronn Sophie, Cloutier Jonathan
Author Information: Division of Surgery, Urology Program, University Hospital of Quebec - Laval University
Written By: Zhamshid Okhunov (Twitter: @OkhunovZham), (Department of Urology, University of California-Irvine) medical writer for UroToday.com at the 73rd Canadian Urological Association Annual Meeting - June 23 - 26, 2018 - Halifax, Nova Scotia